Q9Z2F2
Gene name |
Oasl2 |
Protein name |
2'-5'-oligoadenylate synthase-like protein 2 |
Names |
54 kDa 2'-5'-oligoadenylate synthase-like protein, p54 OASL, M1204 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:23962 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9Z2F2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9Z2F2-F1 | Predicted | AlphaFoldDB |
42 variants for Q9Z2F2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388789562 | 52 | E>K | No | EVA | |
| rs3396196387 | 73 | G>V | No | EVA | |
| rs32140123 | 75 | T>M | No | EVA | |
| rs3388784292 | 81 | D>V | No | EVA | |
| rs32141034 | 95 | E>K | No | EVA | |
| rs13463536 | 102 | E>D | No | EVA | |
| rs3388774781 | 120 | A>D | No | EVA | |
| rs32141035 | 124 | I>F | No | EVA | |
| rs3388772133 | 128 | H>Q | No | EVA | |
| rs3395682302 | 130 | E>G | No | EVA | |
| rs29822904 | 134 | A>P | No | EVA | |
| rs29822904 | 134 | A>T | No | EVA | |
| rs3388789618 | 177 | E>D | No | EVA | |
| rs32141038 | 185 | Y>H | No | EVA | |
| rs3388772104 | 206 | V>I | No | EVA | |
| rs3388789605 | 221 | Q>L | No | EVA | |
| rs3388789572 | 241 | L>M | No | EVA | |
| rs3388753746 | 256 | S>N | No | EVA | |
| rs3388753725 | 257 | F>I | No | EVA | |
| rs3388777495 | 273 | Y>F | No | EVA | |
| rs32142001 | 274 | R>H | No | EVA | |
| rs3388753724 | 282 | K>N | No | EVA | |
| rs3388786221 | 288 | N>Y | No | EVA | |
| rs246493875 | 320 | K>N | No | EVA | |
| rs3388776392 | 330 | A>D | No | EVA | |
| rs3388783931 | 335 | Q>* | No | EVA | |
| rs32142969 | 339 | T>R | No | EVA | |
| rs229463169 | 345 | E>K | No | EVA | |
| rs3396091067 | 351 | R>G | No | EVA | |
| rs245249232 | 351 | R>P | No | EVA | |
| rs265278756 | 352 | A>S | No | EVA | |
| rs3396029785 | 353 | R>K | No | EVA | |
| rs255682007 | 431 | F>I | No | EVA | |
| rs3388776328 | 433 | P>H | No | EVA | |
| rs32145416 | 450 | T>A | No | EVA | |
| rs3388764463 | 456 | T>I | No | EVA | |
| rs3388783375 | 469 | G>D | No | EVA | |
| rs218463708 | 472 | A>V | No | EVA | |
| rs252740003 | 476 | V>I | No | EVA | |
| rs3388774829 | 479 | L>* | No | EVA | |
| rs32145417 | 491 | K>E | No | EVA | |
| rs13463538 | 508 | D>H | No | EVA |
No associated diseases with Q9Z2F2
5 regional properties for Q9Z2F2
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Ubiquitin-like domain | 435 - 506 | IPR000626 |
| domain | 2-5OAS/ClassI-CCAase, nucleotidyltransferase domain | 29 - 214 | IPR006116 |
| conserved_site | 2-5-oligoadenylate synthetase, C-terminal conserved site | 303 - 313 | IPR006117 |
| domain | 2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal | 170 - 351 | IPR018952 |
| conserved_site | 2-5-oligoadenylate synthetase, N-terminal conserved site | 68 - 87 | IPR043518 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| 2'-5'-oligoadenylate synthetase activity | Catalysis of the reaction: ATP = pppA(2'p5'A)n oligomers. This reaction requires the binding of double-stranded RNA. |
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| double-stranded RNA binding | Binding to double-stranded RNA. |
| metal ion binding | Binding to a metal ion. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
| innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| interleukin-27-mediated signaling pathway | The series of molecular signals initiated by interleukin-27 binding to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| negative regulation of viral genome replication | Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication. |
| purine nucleotide biosynthetic process | The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar. |
| regulation of ribonuclease activity | Any process that modulates the rate, frequency, or extent of ribonuclease activity, catalysis of the hydrolysis of phosphodiester bonds in chains of RNA. |
| response to virus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
5 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q2T9Q2 | UBL4B | Ubiquitin-like protein 4B | Bos taurus (Bovine) | PR |
| P11441 | UBL4A | Ubiquitin-like protein 4A | Homo sapiens (Human) | PR |
| Q9CQ84 | Ubl4b | Ubiquitin-like protein 4B | Mus musculus (Mouse) | PR |
| P11928 | Oas1a | 2'-5'-oligoadenylate synthase 1A | Mus musculus (Mouse) | PR |
| Q5MYT9 | Oasl2 | 2'-5'-oligoadenylate synthase-like protein 2 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDPFPDLYAT | PGDSLDHFLE | HSLQPQRDWK | EEGQDAWERI | ERFFREQCFR | DELLLDQEVR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VIKVVKGGSS | GKGTTLNHRS | DQDMILFLSC | FSSFEEQARN | REVVISFIKK | RLIHCSRSLA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YNIIVLTHRE | GKRAPRSLTL | KVQSRKTDDI | IWMDILPAYD | ALGPISRDSK | PAPAIYETLI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RSKGYPGDFS | PSFTELQRHF | VKTRPVKLKN | LLRLVKFWYL | QCLRRKYGRG | AVLPSKYALE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LLTIYAWEMG | TESSDSFNLD | EGFVAVMELL | VNYRDICIYW | TKYYNFQNEV | VRNFLKKQLK |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GDRPIILDPA | DPTNNLGRRK | GWEQVAAEAA | FCLLQVCCTT | VGPSERWNVQ | RARDVQVRVK |
| 370 | 380 | 390 | 400 | 410 | 420 |
| QTGTVDWTLW | TNPYSPIRKM | KAEIRREKNF | GGELRISFQE | PGGERQLLSS | RKTLADYGIF |
| 430 | 440 | 450 | 460 | 470 | 480 |
| SKVNIQVLET | FPPEILVFVK | YPGGQSKPFT | IDPDDTILDL | KEKIEDAGGP | CAEDQVLLLD |
| 490 | 500 | ||||
| DEELEDDESL | KELEIKDCDT | IILIRVID |